Regeneron Pharmaceuticals Inc (REGN.O) Analysts | Reuters.com
Edition:
United States

Regeneron Pharmaceuticals Inc (REGN.O)

REGN.O on Nasdaq

339.78USD
28 Jun 2016
Change (% chg)

-- (--)
Prev Close
$339.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
942,208
52-wk High
$605.93
52-wk Low
$329.09

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.62 December 29 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 7 7 7 9
(2) OUTPERFORM 5 5 5 5
(3) HOLD 12 12 12 11
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.28 2.28 2.28 2.15

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 21 1,239.27 1,330.69 1,182.45 1,040.07
Quarter Ending Sep-16 21 1,300.75 1,413.74 1,219.60 1,052.92
Year Ending Dec-16 25 5,106.46 5,510.61 4,808.90 4,470.16
Year Ending Dec-17 25 6,008.97 6,884.69 5,345.07 5,367.53
Earnings (per share)
Quarter Ending Jun-16 22 2.62 3.05 1.93 2.99
Quarter Ending Sep-16 22 2.78 3.59 1.86 2.98
Year Ending Dec-16 24 10.90 12.43 8.04 13.45
Year Ending Dec-17 25 15.51 28.28 10.93 16.96
LT Growth Rate (%) 8 18.89 36.00 10.30 20.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 1,175.54 1,200.85 25.31 2.15
Quarter Ending Dec-15 1,168.48 1,098.08 70.40 6.03
Quarter Ending Sep-15 1,051.61 1,137.42 85.81 8.16
Quarter Ending Jun-15 887.80 998.62 110.82 12.48
Quarter Ending Mar-15 824.64 869.61 44.98 5.45
Earnings (per share)
Quarter Ending Mar-16 2.58 2.57 0.01 0.43
Quarter Ending Dec-15 3.36 2.83 0.53 15.74
Quarter Ending Sep-15 3.20 3.47 0.27 8.58
Quarter Ending Jun-15 2.77 2.89 0.12 4.28
Quarter Ending Mar-15 2.68 2.88 0.20 7.36

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 1,239.27 1,239.27 1,238.87 1,238.96 1,040.07
Quarter Ending Sep-16 1,300.75 1,300.75 1,298.75 1,306.08 1,052.92
Year Ending Dec-16 5,106.46 5,113.94 5,112.00 5,092.11 4,470.16
Year Ending Dec-17 6,008.97 6,008.97 6,017.66 5,994.50 5,367.53
Earnings (per share)
Quarter Ending Jun-16 2.62 2.62 2.65 2.75 2.99
Quarter Ending Sep-16 2.78 2.78 2.83 3.00 2.98
Year Ending Dec-16 10.90 10.84 10.98 11.53 13.45
Year Ending Dec-17 15.51 15.51 15.88 16.31 16.96

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 0 2
Year Ending Dec-16 0 0 0 2
Year Ending Dec-17 0 0 1 1
Earnings
Quarter Ending Jun-16 0 0 0 1
Quarter Ending Sep-16 0 0 0 1
Year Ending Dec-16 0 0 0 2
Year Ending Dec-17 0 0 0 3

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.